M. Buemi et al., Effects of lisinopril administration on blood bcl-2 concentrations in patients with immunoglobulin A nephropathy, CLIN PHARM, 65(6), 1999, pp. 649-652
We evaluated blood concentrations of bcl-2, a proto-oncogene that can inhib
it apoptotic phenomena, in a group of patients with immunoglobulin A (IgA)
nephropathy, Concentrations of bcl-2 were higher in patients with proteinur
ia than in those without proteinuria, A 6-month course of 5 mg/day lisinopr
il given to subjects with proteinuria significantly reduced blood bcl-2 con
centrations and caused a reduction in proteinuria. Therefore increased bloo
d bcl-2 concentrations may be considered an index of risk in subjects with
IgA nephropathy, and the positive effects of angiotensin-converting enzyme
inhibitors on proteinuria in patients with IgA nephropathy may be attribute
d, at least in part, to their effect on the mechanisms that regulate apopto
sis, This is of fundamental importance in resolving glomerular hypercellula
rity in the course of glomerulonephritis.